Jennie XU _ PhD
LightNews LightNews
drjenniexu.bsky.social
Jennie XU _ PhD
@drjenniexu.bsky.social
7 followers 35 following 21 posts
Posts Replies Media Videos
drjenniexu.bsky.social
SGLT2 inhibitors in hemodialysis or peritoneal dialysis patients: rationale and state-of-the art
#OpenAccess
Full text 👉https://buff.ly/VrurlWC

#Cardiovascular
#Haemodialysis
#PeritonealDialysis
#PeritonealMembrane
#SGLT2Inhibitors
#Nephrology
#KidneyCare
#nephsky
#medsky
SGLT2 inhibitors in hemodialysis or peritoneal dialysis patients: rationale and state-of-the art
Abstract. Sodium-glucose cotransporter-2 inhibitors (SGLT2i) reduce the risk of end-stage kidney disease (ESKD), cardiovascular events, and all-cause morta
doi.org
November 24, 2025 at 9:40 PM
drjenniexu.bsky.social
Nutritional Recommendations for Pregnant Women Receiving #Dialysis: A Scoping Review
#OpenAccess
Full text 👉 buff.ly/A0UdRRC

#Pregnancy
#Nutrition
#DialysisDiet
#BreastfeedingSupport
#NutritionalGuidelines
#KidneyCare
#KidneyHealth
#nephsky
#medsky
November 23, 2025 at 1:54 PM
drjenniexu.bsky.social
Summary of the clinical approach to hypotonic hyponatremia
by Prof. Dr. Goce Spasovski
#OpenAccess

Full text 👉https://buff.ly/DFzymro

#Hyponatremia
#Tonicity
#Volemia
#AcuteHyponatremia
#Chronic
#Nephrology
#KidneyCare
#nephsky
#medsky
www.mdpi.com
November 22, 2025 at 1:56 PM
drjenniexu.bsky.social
Acute Kidney Injury Associated with Severe Leptospirosis: Fatal Re-Emerging Disease in Latin America
#OpenAccess
Full text 👉 buff.ly/zbXEJsM

#Leptospirosis
#AcuteKidneyInjury
#ZoonoticDisease
#Antibiotics
#PublicHealth
#AKI
#Nephrology
#KidneyCare
#nephsky
#medsky
November 22, 2025 at 12:19 AM
drjenniexu.bsky.social
An Update on Hypomagnesemia and Hypermagnesemia
by Prof. Dr. Steven Van Laecke
#OpenAccess
Full text 👉 buff.ly/V5dLdPm

#Hypomagnesemia
#Hypermagnesemia
#MagnesiumDeficiency
#CKD
#DiabetesManagement
#Nephrology
#KidneyCare
#nephsky
#medsky
November 19, 2025 at 1:23 AM
Reposted by Jennie XU _ PhD
nkf-professionals.bsky.social
When is not starting dialysis the most compassionate choice? 🩺💭

Join Dr. Rosen with Drs. Moss and Corbett as they explore the ethical, clinical, and emotional factors in deciding when to withhold dialysis at the end of life.

🎧
Kidney Commute
Tune in for the latest research and perspectives on kidney health from NKF.
bit.ly
November 18, 2025 at 1:00 AM
Reposted by Jennie XU _ PhD
brianrifkin.bsky.social
New Freely Filtered, live from ASN #NephSky

podcasts.apple.com/us/podcast/f...
FF 85 Live! From Houston, The KidneyWk Draft
Podcast Episode · Freely Filtered, a NephJC Podcast · 11/17/2025 · 50m
podcasts.apple.com
November 18, 2025 at 2:46 AM
Reposted by Jennie XU _ PhD
natrevneph.nature.com
In December: Guidelines for the use of economic evaluation to inform KRT policies, Reviews on organ perfusion; physical activity; and long COVID, plus Commentaries on the WHO kidney health resolution; NIH grant terminations; transplantation in Nepal; and lived experience go.nature.com/3JDxzIg
Screenshot of the TOC for the December issue of Nature Reviews Nephrology.
November 18, 2025 at 5:46 AM
Reposted by Jennie XU _ PhD
kireports.bsky.social
Clinicopathological Spectrum and Treatment Outcomes of #Cryofibrinogen associated Nephropathies

#VisualAbstract by Brian Rifkin

https://www.kireports.org/article/S2468-0249(25)00666-7/fulltext

@JulienVPDang
November 17, 2025 at 2:00 PM
Reposted by Jennie XU _ PhD
natrevneph.nature.com
Slowing of progress in reducing non-communicable disease mortality
Nature Reviews Nephrology, Published online: 12 November 2025; doi:10.1038/s41581-025-01033-1A new study reports that in 2010–2019, mortality owing to non-communicable diseases continued to decline in the majority of countries worldwide. However, the data also highlight major disparities between countries and a widespread slowing of progress in reducing mortality compared to the previous decade.
www.nature.com
November 18, 2025 at 9:28 AM
Reposted by Jennie XU _ PhD
edgarvlermamd.bsky.social
Empowering the Next Generation of Nephrologists: Trainee Opportunities in #GlomCon Ecosystem from @asnpublications.bsky.social @glomcon.org @bettercallseeth.bsky.social @saynanorouzi.bsky.social @nephrologista.bsky.social @poyanmehr.org
#Nephpearls #NephSky

👉 pubmed.ncbi.nlm.nih.gov/41105470/
October 18, 2025 at 3:09 PM
Reposted by Jennie XU _ PhD
nephroseeker.medsky.social
📅 Coming next week, October 23, 2025, at 5:00 PM (CEST) #Nephsky #Medsky

✨E-seminar: Interventional Nephrology- A Beginner’s Guide for Young Nephrologists

🎙️Presenting @drbarbateba.bsky.social
💬Moderator @hugodiniz.medsky.social

👉You can register here
www.era-online.org/video-pages/...
Interventional Nephrology: A Beginner’s Guide for Young Nephrologists | ERA
Register for the YNP e-Seminar on Interventional Nephrology: A Beginner’s Guide for Young Nephrologists.
www.era-online.org
October 19, 2025 at 7:08 PM
Reposted by Jennie XU _ PhD
hswapnil.medsky.social
The latest empadata dump: @nephroseeker.medsky.social writes up a #NephJC short on the meta analysis

www.nephjc.com/news/2025/10...
Empagliflozin, the kidney, and what we still don’t understand — NephJC
NephJC short on an empagliflozin meta-analysis
www.nephjc.com
October 21, 2025 at 12:03 AM
Reposted by Jennie XU _ PhD
nephjc.bsky.social
❤️Check out the VA for the discussion on the AHA/ACC Hypertension Guidelines 9/16/25 at 9pm EST by @sejalplakhani.bsky.social #NephJC #NephSky #MedSky
www.nephjc.com/news/2025/9/ahaacc-htnguide
The AHA/ACC 2025 Hypertension Guidelines visual abstract — NephJC
New updated guidance on hypertension including screening for secondary causes, use of renal denervation, hypertension and pregnancy, risk assessment, monitoring and treatment. Check out this wonderfu...
www.nephjc.com
September 16, 2025 at 11:47 AM
Reposted by Jennie XU _ PhD
chillslincoln79.bsky.social
📣 Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-clinical trial @naturemedicine.bsky.social 👩‍🔬🥼🧪👨‍🔬 #Semaglutide #KidneyDisease #Obesity #kidney #NephroSky #CardioSky #NephSky 👇👇👇
pubmed.ncbi.nlm.nih.gov/39455729/
Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial - PubMed
Semaglutide reduces albuminuria and the risk of kidney disease progression in patients with type 2 diabetes and chronic kidney disease (CKD). We conducted a randomized placebo-controlled double-blind ...
pubmed.ncbi.nlm.nih.gov
January 29, 2025 at 6:16 PM
Reposted by Jennie XU _ PhD
kidneystories.bsky.social
N.B. woman feels fulfilled by kidney donation to cousin in Ontario - CBC - goo.gl/alerts/tAh5Qr #GoogleAlerts
N.B. woman feels fulfilled by kidney donation to cousin in Ontario
goo.gl
September 16, 2025 at 6:56 PM
drjenniexu.bsky.social
The Two Levels of Podocyte Dysfunctions Induced by Apolipoprotein L1 Risk Variants
#OpenAccess
Full text 👉 buff.ly/eNYwDuQ

#APOL1
#nephropathy
#podocyte
#dysfunction
#apoptosis
#Nephrology
#KidneyCare
#nephsky
#medsky
#RenalPath
September 12, 2025 at 11:19 PM
Reposted by Jennie XU _ PhD
jonathanpollack.bsky.social
ICYMI: FILSPARI passes a hurdle on the way to FDA approval for FSGS.

#FSGS #NephSky #IgAN #nephrology #kidneydisease
Travere Therapeutics Provides Update on FDA Advisory Committee Meeting for FILSPARI® (sparsentan) in FSGS
Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that following further review of the supplemental New Drug Applicat...
ir.travere.com
September 11, 2025 at 2:02 AM
Reposted by Jennie XU _ PhD
baladocritique.bsky.social
"Treatment standard: CKD in the geriatric patient."
Publié en septembre dans NDT.
#MedSky #NephSky
academic.oup.com/ndt/article/...
Treatment standard: CKD in the geriatric patient
ABSTRACT. The number of older people with chronic kidney disease (CKD) is increasing globally. The vast majority of these patients will die before they eve
academic.oup.com
September 11, 2025 at 2:50 PM
Reposted by Jennie XU _ PhD
ajkd.bsky.social
Editorial by Maarten W. Taal et al.

Kidney Protective Effects of Glucagon-Like Peptide-1 Receptor Agonists Versus Sodium/Glucose Cotransporter 2 Inhibitors in Persons With Diabetes and CKD: Implications for Personalized Medicine

bit.ly/41MZLOC (FREE)
September 10, 2025 at 4:02 PM
Reposted by Jennie XU _ PhD
arkanalabs.bsky.social
A sample from the pathology teaching slide set on Hepatitis B Infection-Related Glomerulonephritis, jointly prepared by Arkana Laboratories and @goKDIGO. http://KDIGO.org/guidelines/gd/

#KDIGO #pathology #renal #renalpath
September 10, 2025 at 1:02 PM
Reposted by Jennie XU _ PhD
jzrenalpath.bsky.social
Lupus nephritis case with prominent podocyte cytoplasmic vacuolization on LM with myelin figures revealed by EM. Probably HCQ effect but given its prominence genetic etiologies should be excluded (e.g., Fabry, LMX1B). #renalpath #pathsky #nephsky
September 8, 2025 at 11:06 PM
drjenniexu.bsky.social
Hypercalcemia: A Practice Overview of Its Diagnosis and Causes

Full text 👉 buff.ly/zwMMnCi

#Hypercalcemia
#Calcium
#PTH
#HealthAwareness
#Nephrology
#KidneyCare
#KidneyHealth
#nephsky
#medsky
#RenalPath
#OpenAccess
www.mdpi.com
September 10, 2025 at 12:23 AM
Reposted by Jennie XU _ PhD
nephjc.bsky.social
🤔 How often is end-stage kidney disease in patients with MCD/ FSGS? #NephSky #MedSky

@brianrifkin.bsky.social dissected the conclusions from the RaDar study in this #NephJCshorts

*the original article from @asnpublications.bsky.social

www.nephjc.com/news/nephjc-...
NephJC Shorts: MCD and FSGS Outcomes — NephJC
A NephJC Shorts discussion of the long term data on kidney failure in FSGS and MCD
www.nephjc.com
September 6, 2025 at 5:00 PM
drjenniexu.bsky.social
unbelievable
www.nature.com/articles/s41...
Parkinson disease pathology can originate in the kidney - Nature Reviews Neurology
New research suggests that pathological α-synuclein in Parkinson disease can propagate from kidney to brain.
www.nature.com
September 9, 2025 at 9:05 PM